ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002424 ST百灵

已收盘 11-22 15:00:00

{"stockData":{"symbol":"002424","market":"SZ","secType":"STK","nameCN":"ST百灵","latestPrice":4.03,"timestamp":1732258992000,"preClose":4.06,"halted":0,"volume":41717200,"delay":0,"floatShares":1213000000,"shares":1398000000,"eps":-0.334,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"11-22 15:00:00","open":4.06,"high":4.23,"low":4.02,"amount":172000000,"amplitude":0.0517,"askPrice":4.04,"askSize":1991,"bidPrice":4.03,"bidSize":3966,"shortable":0,"etf":0,"ttmEps":-0.334,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":4.06,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":4.26,"lowLimit":3.86,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1397598400,"pbRate":1.63,"roa":"--","roe":"2.55%","epsLYR":-0.3,"committee":0.295263,"marketValue":5632000000,"floatMarketCap":4889000000,"peRate":-12.065869,"changeRate":-0.0074,"turnoverRate":0.0344,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-11-25。"},"requestUrl":"/m/hq/s/002424","defaultTab":"news","newsList":[{"id":"2484929119","title":"ST百灵(002424)11月8日股东户数8.86万户，较上期增加0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484929119","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484929119?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:02","pubTimestamp":1732006961,"startTime":"0","endTime":"0","summary":"证券之星消息，近日ST百灵披露，截至2024年11月8日公司股东户数为8.86万户，较10月31日增加314.0户，增幅为0.36%。在中药行业个股中，ST百灵股东户数高于行业平均水平，截至11月8日，中药行业平均股东户数为5.04万户。从股价来看，2024年10月31日至2024年11月8日，ST百灵区间涨幅为8.36%，在此期间股东户数增加314.0户，增幅为0.36%。根据统计，ST百灵2024年10月31日至2024年11月8日，主力资金净流出6685.0万元，游资资金净流入2221.98万元，散户资金净流入4463.02万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900027217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0239","BK0077","BK0188","BK0028","BK0146","002424"],"gpt_icon":0},{"id":"2484993339","title":"ST百灵:涉嫌信息披露违法违规调查详情披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2484993339","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484993339?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:25","pubTimestamp":1732001100,"startTime":"0","endTime":"0","summary":"关于公司收到中国证券监督管理委员会下发《立案告知书》的事项，公司在此对投资者致以诚挚的歉意。立案调查期间，公司将积极配合中国证监会的各项调查工作，并严格按照相关法律法规和监管要求及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-11-19/doc-incwqrfs2960081.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-11-19/doc-incwqrfs2960081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0188","BK0239","002424","BK0183","BK0028","BK0077"],"gpt_icon":0},{"id":"2484661787","title":"异动快报：ST百灵（002424）11月18日9点38分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2484661787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484661787?lang=zh_cn&edition=full","pubTime":"2024-11-18 09:40","pubTimestamp":1731894035,"startTime":"0","endTime":"0","summary":"证券之星11月18日盘中消息，9点38分ST百灵触及跌停板。目前价格4.09，下跌4.88%。其所属行业中药目前上涨。11月15日的资金流向数据方面，主力资金净流出7842.38万元，占总成交额20.06%，游资资金净流入3110.39万元，占总成交额7.96%，散户资金净流入4731.99万元，占总成交额12.1%。近5日资金流向一览见下表：ST百灵主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800003241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0077","BK0239","BK0146","002424","BK0188"],"gpt_icon":0},{"id":"2483037395","title":"异动快报：ST百灵（002424）11月15日11点23分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2483037395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483037395?lang=zh_cn&edition=full","pubTime":"2024-11-15 11:25","pubTimestamp":1731641116,"startTime":"0","endTime":"0","summary":"证券之星11月15日盘中消息，11点23分ST百灵（002424）触及跌停板。目前价格4.3，下跌5.08%。其所属行业中药目前下跌。领涨股为香雪制药。该股为腾讯概念股，流感，互联网医疗概念热股，当日腾讯概念股概念上涨0.28%。11月14日的资金流向数据方面，主力资金净流入3167.63万元，占总成交额8.9%，游资资金净流出2170.14万元，占总成交额6.1%，散户资金净流出997.49万元，占总成交额2.8%。近5日资金流向一览见下表：ST百灵主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500014948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0146","BK0183","002424","BK0188","BK0239"],"gpt_icon":0},{"id":"2483025117","title":"贵州百灵（002424）被证监会立案投资者已可索赔，力源科技（688565）索赔案持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2483025117","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483025117?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:32","pubTimestamp":1731483120,"startTime":"0","endTime":"0","summary":"　　2024年11月8日，贵州百灵公告收到证监会下发的《立案告知书》，因公司涉嫌信息披露违法违规，根据《证券法》《行政处罚法》等法律法规，证监会决定对公司立案。　　上海久诚律师事务所许峰律师提示，目前贵州百灵投资者已可初步发起索赔，在2022年4月23日到2024年4月30日之间买入贵州百灵股票，并且在2024年4月30日后卖出或持有股票的投资者，初步可做起诉的相关工作。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-13/doc-incvxarn8109638.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-13/doc-incvxarn8109638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0188","BK0183","BK0146","688565","002424","BK0077","BK0251","BK0218","BK0028"],"gpt_icon":0},{"id":"2483049801","title":"异动快报：ST百灵（002424）11月13日13点42分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2483049801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483049801?lang=zh_cn&edition=full","pubTime":"2024-11-13 13:45","pubTimestamp":1731476720,"startTime":"0","endTime":"0","summary":"证券之星11月13日盘中消息，13点42分ST百灵（002424）触及涨停板。目前价格4.31，上涨5.12%。其所属行业中药目前下跌。领涨股为启迪药业。该股为腾讯概念股，互联网医疗，流感概念热股。11月13日的资金流向数据方面，主力资金净流出2668.82万元，占总成交额9.7%，游资资金净流入973.23万元，占总成交额3.54%，散户资金净流入1695.59万元，占总成交额6.16%。近5日资金流向一览见下表：ST百灵主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300018585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0239","002424","BK0077","BK0188","BK0146","BK0028"],"gpt_icon":0},{"id":"2483091609","title":"贵州百灵（002424）被正式立案调查，一年内三收监管函","url":"https://stock-news.laohu8.com/highlight/detail?id=2483091609","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483091609?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:12","pubTimestamp":1731460320,"startTime":"0","endTime":"0","summary":"　　2024年11月8日，贵州百灵企业集团制药股份有限公司 收到中国证券监督管理委员会下发的《立案告知书》。因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。　　信本股民索赔团队提醒，ST百灵被证监会立案调查，因此受损的投资者，可通过“信本股民索赔”自愿发起索赔登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-13/doc-incvwmtu8325082.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-13/doc-incvwmtu8325082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","BK0146","002424","BK0188","BK0028","BK0077","BK0239"],"gpt_icon":0},{"id":"2482773118","title":"ST百灵(002424.SZ)：糖宁通络片临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2482773118","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482773118?lang=zh_cn&edition=full","pubTime":"2024-11-12 17:39","pubTimestamp":1731404352,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST百灵(002424.SZ)公告，公司全资子公司百灵毓秀(珠海)医药有限公司(简称“百灵毓秀”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》，由百灵毓秀申报的糖宁通络片临床试验申请获得批准，同意本品开展用于糖尿病视网膜病变的Ⅲ期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","03347","BK0239","002424","BK0183","BK0188","BK0028","BK1576","BK0146","BK1583","BK1141"],"gpt_icon":0},{"id":"2482458287","title":"异动快报：ST百灵（002424）11月12日13点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2482458287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482458287?lang=zh_cn&edition=full","pubTime":"2024-11-12 13:15","pubTimestamp":1731388522,"startTime":"0","endTime":"0","summary":"证券之星11月12日盘中消息，13点14分ST百灵触及涨停板。目前价格4.14，上涨5.08%。该股为民营医院，互联网医疗，流感概念热股，当日民营医院概念上涨4.45%，互联网医疗概念上涨2.86%，流感概念上涨2.85%。近5日资金流向一览见下表：ST百灵主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200018261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0188","BK0077","BK0146","002424","BK0239"],"gpt_icon":0},{"id":"2482711111","title":"贵州百灵（002424）被立案，股民索赔可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2482711111","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482711111?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:21","pubTimestamp":1731381660,"startTime":"0","endTime":"0","summary":"　　2024年11月9日，贵州百灵企业集团制药股份有限公司发布《关于收到中国证券监督管理委员会立案告知书的公告》，称因公司涉嫌信息披露违法违规等行为，根据《证券法》的有关规定，中国证监会决定对公司立案调查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-12/doc-incvupap6480732.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-12/doc-incvupap6480732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0183","BK0028","BK0077","BK0239","BK0188","002424"],"gpt_icon":0},{"id":"2482977978","title":"贵州百灵，病了吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2482977978","media":"斑马消费","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482977978?lang=zh_cn&edition=full","pubTime":"2024-11-12 07:43","pubTimestamp":1731368580,"startTime":"0","endTime":"0","summary":"去年12月，贵州证监局对ST百灵及多名高管采取行政监管措施。头顶“苗药第一股”的光环，贵州百灵上市后，业绩持续增长，推动公司股价节节高涨。截至今年8月29日，姜伟持有贵州百灵2.45亿股，占公司总股本的17.55%，这些股票已被全部质押。2021年，以医药为核心的贵州百灵，出资2.08亿元和6100万元，收购姜伟家族旗下的百灵温泉酒店以及贵州银行股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI0MDY2ODM2MQ==&mid=2247513608&idx=2&sn=16ca8bbc833569b64872ba2a12394979&chksm=e83785ad6b52c0ad7fe74a5dfd18e79de0be5438a86ce3d02851ccda3104cd9237bd6d792cda&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0183","BK0239","BK0077","BK0188","BK0028","BK0146","002424"],"gpt_icon":0},{"id":"2482270840","title":"ST百灵(002424)10月31日股东户数8.83万户，较上期减少0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482270840","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482270840?lang=zh_cn&edition=full","pubTime":"2024-11-11 17:03","pubTimestamp":1731315788,"startTime":"0","endTime":"0","summary":"证券之星消息，近日ST百灵披露，截至2024年10月31日公司股东户数为8.83万户，较10月18日减少316.0户，减幅为0.36%。在中药行业个股中，ST百灵股东户数高于行业平均水平，截至10月31日，中药行业平均股东户数为5.03万户。从股价来看，2024年10月18日至2024年10月31日，ST百灵区间涨幅为12.65%，在此期间股东户数减少316.0户，减幅为0.36%。根据统计，ST百灵2024年10月18日至2024年10月31日，主力资金净流出2685.85万元，游资资金净流出98.48万元，散户资金净流入2784.33万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100021856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","BK0146","002424","BK0077","BK0239","BK0028"],"gpt_icon":0},{"id":"2482603241","title":"ST百灵信披违规被立案，投资索赔预登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2482603241","media":"市场资讯","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482603241?lang=zh_cn&edition=full","pubTime":"2024-11-11 11:06","pubTimestamp":1731294360,"startTime":"0","endTime":"0","summary":"　　2024年11月9日贵州百灵企业集团制药股份有限公司发布公告称，公司收到中国证券监督管理委员会下发的《立案告知书》。因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。　　此前，ST百灵内部控制审计报告被出具否定意见。　　罗建欣律师代理的部分投资者诉ST百灵证券虚假陈述案目前正在有序推进，符合条件的投资者尽快加入索赔。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvk8829345.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvk8829345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0183","002424","BK0188","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2482241932","title":"ST百灵信披违规，股民须关注索赔条件！","url":"https://stock-news.laohu8.com/highlight/detail?id=2482241932","media":"市场资讯","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482241932?lang=zh_cn&edition=full","pubTime":"2024-11-11 11:01","pubTimestamp":1731294060,"startTime":"0","endTime":"0","summary":"　　按照申万行业分类，ST百灵（维权）属于医药生物-中药Ⅱ-中药Ⅲ。　　2024年11月8日晚，公司因违规信披被立案调查。贵州百灵公司与市场开拓及促销费用等相关的内部控制存在计提不及时、不完整等重大缺陷。截至 2023年12月31日，贵州百灵公司用于生产某种苗药产品主要原材料账面余额 2. 16 亿元，跌价准备 0.56 亿元，账面价值 1.60 亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvr7574078.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvr7574078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0028","BK0239","BK0188","BK0077","BK0183","002424"],"gpt_icon":0},{"id":"2482249355","title":"远兴能源、ST百灵遭证监会立案  投资者或可索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=2482249355","media":"市场资讯","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482249355?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:53","pubTimestamp":1731293580,"startTime":"0","endTime":"0","summary":"　　2024年11月8日晚间，远兴能源（维权）、ST百灵（维权）均发布关于收到中国证券监督管理委员会《立案告知书》的公告。两家上市公司均是因为涉嫌信息披露违法违规遭证监会立案，不同的是远兴能源就上述立案调查事项进行了自查情况说明，而ST百灵则未说明遭立案的原因。　　江苏振泽律师事务所合伙人张云律师表示，远兴能源、ST百灵遭证监会立案，投资者或可索赔。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvr7570960.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvr7570960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0066","BK0229","BK0183","000683","BK0188","BK0028","BK0077","BK0146","002424","BK0239"],"gpt_icon":0},{"id":"2482468962","title":"ST百灵（贵州百灵）股票索赔：涉嫌信披违规被立案，投资者可做索赔准备","url":"https://stock-news.laohu8.com/highlight/detail?id=2482468962","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482468962?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:30","pubTimestamp":1731292200,"startTime":"0","endTime":"0","summary":"　　近日，代理过多件重大影响案件的江苏博爱星律师事务所章祥兵律师特别提示，ST百灵（维权）涉嫌信披违规被立案，投资者可做索赔准备。　　2024年11月9日，贵州百灵企业集团制药股份有限公司发布公告称：“公司收到中国证监会下发的《立案告知书》。因公司涉嫌信息披露违法违规，根据相关法律法规，中国证监会决定对公司立案”。　　目前，章祥兵律师正在开展ST百灵受损投资者索赔预登记工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvq0784494.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-11/doc-incvscvq0784494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","002424","BK0146","BK0239","BK0028","BK0188","BK0077"],"gpt_icon":0},{"id":"2481175123","title":"ST百灵(002424.SZ)因涉嫌信披违法违规 被中国证监会立案","url":"https://stock-news.laohu8.com/highlight/detail?id=2481175123","media":"智通财经","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481175123?lang=zh_cn&edition=full","pubTime":"2024-11-08 19:45","pubTimestamp":1731066355,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST百灵(002424.SZ)发布公告，公司于2024年11月8日收到中国证券监督管理委员会(“中国证监会”)下发的《立案告知书》(编号：证监立案字0312024002号)。因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0028","BK0188","BK0077","BK0146","002424","BK0239"],"gpt_icon":0},{"id":"2481493173","title":"ST百灵最新公告：因涉嫌信息披露违法违规 公司被中国证监会立案调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2481493173","media":"证券之星","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481493173?lang=zh_cn&edition=full","pubTime":"2024-11-08 19:40","pubTimestamp":1731066030,"startTime":"0","endTime":"0","summary":"ST百灵公告称，公司于2024年11月8日收到中国证券监督管理委员会下发的《立案告知书》。因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。公司表示，目前各项生产经营活动均正常开展，立案调查期间将积极配合中国证监会的各项调查工作，并严格按照相关法律法规和监管要求及时履行信息披露义务。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800036792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0239","002424","BK0077","BK0188","BK0146","BK0028"],"gpt_icon":0},{"id":"2481173855","title":"ST百灵：因涉嫌信息披露违法违规 收到中国证监会立案告知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2481173855","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481173855?lang=zh_cn&edition=full","pubTime":"2024-11-08 19:36","pubTimestamp":1731065771,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["BK0146","BK0188","BK0077","BK0183","002424","BK0028","BK0239"],"gpt_icon":0},{"id":"2481695062","title":"异动快报：ST百灵（002424）11月6日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2481695062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481695062?lang=zh_cn&edition=full","pubTime":"2024-11-06 09:36","pubTimestamp":1730856989,"startTime":"0","endTime":"0","summary":"证券之星11月6日盘中消息，9点34分ST百灵（002424）触及涨停板。目前价格4.33，上涨5.1%。其所属行业中药目前上涨。领涨股为中恒集团。该股为腾讯概念股，医药，中药概念热股，当日腾讯概念股概念上涨0.67%，医药概念上涨0.4%，中药概念上涨0.36%。11月5日的资金流向数据方面，主力资金净流出625.95万元，占总成交额4.41%，游资资金净流入755.31万元，占总成交额5.32%，散户资金净流出129.36万元，占总成交额0.91%。近5日资金流向一览见下表：ST百灵主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600010016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","002424","BK0077","BK0239","BK0188","BK0146","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-06-03","address":"贵州省安顺市西秀区经济技术开发区西航路212号","stockEarnings":[{"period":"1week","weight":-0.0628},{"period":"1month","weight":0.0951},{"period":"3month","weight":0.2477},{"period":"6month","weight":-0.0562},{"period":"1year","weight":-0.5242},{"period":"ytd","weight":-0.5031}],"companyName":"贵州百灵企业集团制药股份有限公司","boardCode":"AI0027","perCapita":"13686股","boardName":"医药制造业","registeredCapital":"139759万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":"　　贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的产品主要有银丹心脑通软胶囊、维C银翘片、咳速停糖浆及胶囊、小儿柴桂退热颗粒、金感胶囊、双羊喉痹通颗粒、泌淋清胶囊、康妇灵胶囊、复方一枝黄花喷雾剂、经带宁胶囊、消咳颗粒、糖宁通络胶囊/片、肥料、纯净水。凭借良好的科技创新能力和突出的知识产权优势，公司被认定为“2023年新确定的国家知识产权示范企业”。","serverTime":1732347769669,"listedPrice":40,"stockholders":"88643人(较上一季度增加0.36%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST百灵,002424,ST百灵股票,ST百灵股票老虎,ST百灵股票老虎国际,ST百灵行情,ST百灵股票行情,ST百灵股价,ST百灵股市,ST百灵股票价格,ST百灵股票交易,ST百灵股票购买,ST百灵股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}